Natco Pharma (NSE:NATCOPHARM) Inventories, Finished Goods : ₹0 Mil (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma Inventories, Finished Goods?

Natco Pharma's annual finished goods increased from Mar. 2022 (₹2,129 Mil) to Mar. 2023 (₹2,866 Mil) but then declined from Mar. 2023 (₹2,866 Mil) to Mar. 2024 (₹0 Mil).

Natco Pharma Inventories, Finished Goods Historical Data

The historical data trend for Natco Pharma's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natco Pharma Inventories, Finished Goods Chart

Natco Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Inventories, Finished Goods

Get a 7-Day Free Trial

1,482.00

1,637.00

2,129.00

2,866.00

Natco Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															2,866.00	-	-	-	-

Natco Pharma Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Natco Pharma (NSE:NATCOPHARM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (NSE:NATCOPHARM) » Definitions » Inventories, Finished Goods

Traded in Other Exchanges

524816:India

Address

Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034

Website

https://www.natcopharma.co.in

Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.

Natco Pharma (NSE:NATCOPHARM) Headlines

No Headlines